Issuance of Stock Acquisition Rights to Directors and Executive Officers
First written in FY2017-Q2. 6 of 9 entries say "Advanced", first in FY2017. Latest entry: FY2021.
- FY2021AchievedAnnual report
「① Contents of the stock option plan: Not applicable.」
Following the abolition of the former stock-based stock option plan, no unexercised rights remained, and disclosures indicating the issuance or outstanding balance of stock acquisition rights were discontinued. - FY2020DroppedAnnual report
「At the 13th Annual General Meeting of Shareholders held on 19 June 2020, the Company resolved to abolish its former stock-based stock option plan and introduce a restricted stock compensation plan.」
The Company stated a policy of abolishing the former issuance plan for stock acquisition rights for directors and executive officers and waiving the rights to exercise the unexercised portion. - FY2020-Q2AdvancedAnnual report
「Date of resolution 21 June 2019 Categories and number of grantees (people) Directors (excluding outside directors) 6 people Executive officers (excluding those who are directors) 12 people Number of stock acquisition rights (units)* 417 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common stock 41,700 (Note 2) Exercise period for the stock acquisition rights* 13 July 2019 to 12 July 2049」
For the 2019 stock acquisition rights, 417 rights representing 41,700 underlying shares were issued for 6 directors and 12 executive officers, with an exercise period from 13 July 2019 to 12 July 2049. The operation of the executive share-based compensation plan is progressing. - FY2019AdvancedAnnual report
「Exercised 2,800 3,000 — Remaining unexercised 11,900 15,800 16,200」
The 2016 stock acquisition rights for 2,800 shares and the 2017 stock acquisition rights for 3,000 shares were exercised, while the 2018 stock acquisition rights for 16,200 shares were granted and vested. - FY2019-Q2AdvancedAnnual report
「Date of resolution 22 June 2018 Categories and number of grantees (people) Directors (excluding outside directors) 6 people Executive officers (excluding those who are directors) 9 people Number of stock acquisition rights (units)* 162 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common stock 16,200 (Note 2) Exercise period for the stock acquisition rights* 14 July 2018 to 13 July 2048」
For the 2018 stock acquisition rights for 6 directors and 9 executive officers, 162 rights representing 16,200 underlying shares were issued and an exercise period was established. The operation of the executive share-based compensation plan is progressing. - FY2018AdvancedAnnual report
「After exercise (shares) End of previous consolidated fiscal year 16,600 Exercised 1,900 Remaining unexercised 14,700」
Of the 2016 stock acquisition rights, 1,900 shares were exercised during the year. The 18,800 2017 stock acquisition rights were also granted and vested, indicating progress in the operation of the executive share-based compensation plan. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Date of resolution 22 June 2017 Number of stock acquisition rights (units) 188 (Note 1) Number of shares underlying the stock acquisition rights (shares) 18,800 (Note 2) Exercise period for the stock acquisition rights 15 July 2017 to 14 July 2047」
For the 2017 stock acquisition rights for directors and executive officers, 188 rights representing 18,800 underlying shares were issued, with an exercise period from 15 July 2017 to 14 July 2047. The implementation of the issuance was confirmed from the previous resolution stage. - FY2017AdvancedAnnual report
「② Resolved at the Board of Directors meeting held on 22 June 2017 DaikyoNishikawa Corporation 2017 Stock Acquisition Rights Categories and number of grantees Directors (excluding outside directors) 6 people Executive officers (excluding those who are directors) 9 people Number of shares 18,800 shares (Note 1)」
In addition to disclosing the remaining 2016 stock acquisition rights, the Company approved 18,800 2017 stock acquisition rights for 6 directors and 9 executive officers. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Number of stock acquisition rights (units) 184 (Note 1) Number of shares underlying the stock acquisition rights (shares) 18,400 (Note 2) Exercise period for the stock acquisition rights 16 July 2016 to 15 July 2046」
The Company issued 184 stock acquisition rights for directors and executive officers, representing 18,400 underlying shares. The exercise period runs from 16 July 2016 to 15 July 2046.